(Q32060398)

6 July 2017

1 reference

title

Anticancer drug-induced kidney disorders (English)

1 reference

6 July 2017

P E Kintzel

1

1 reference

6 July 2017

1 January 2001

1 reference

6 July 2017

1 reference

6 July 2017

24

1 reference

6 July 2017

1

1 reference

6 July 2017

19-38

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200124010-00003

6 July 2017

0 references

cites work

Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding

1 reference

12 December 2020

Cis-diamminedichloroplatinum (NSC-119875): a phase I study

1 reference

12 December 2020

Nephrotoxicity of semustine

1 reference

12 December 2020

Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity

1 reference

12 December 2020

Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome

1 reference

12 December 2020

Renal tubular function in patients treated with high-dose cisplatin

1 reference

12 December 2020

A new strategy for characterizing proteinuria and haematuria from a single pattern of defined proteins in urine

1 reference

12 December 2020

CCNU nephrotoxicity following sustained remission in oat cell carcinoma

1 reference

12 December 2020

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

1 reference

12 December 2020

Human renal Fanconi syndrome--then and now

1 reference

12 December 2020

A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study

1 reference

12 December 2020

Hypomagnesemia after cisplatin combination chemotherapy

1 reference

12 December 2020

An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Renal disease after mitomycin C therapy

1 reference

12 December 2020

Chronic Renal Failure in Children Treated with Methyl CCNU

1 reference

12 December 2020

The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells

1 reference

12 December 2020

Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.

1 reference

12 December 2020

Use of Serum Creatinine Concentrations to Determine Renal Function1

1 reference

12 December 2020

Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report

1 reference

12 December 2020

In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin

1 reference

12 December 2020

Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study

1 reference

12 December 2020

Human pharmacokinetics of WR-2721

1 reference

12 December 2020

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

12 December 2020

Mitomycin-associated renal failure. Case report and review

1 reference

12 December 2020

Modification of cisplatin toxicity with diethyldithiocarbamate.

1 reference

12 December 2020

Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.

1 reference

12 December 2020

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males

1 reference

12 December 2020

Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors

1 reference

12 December 2020

Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy

1 reference

12 December 2020

Hemolytic uremic syndrome associated with cisplatin therapy

1 reference

12 December 2020

A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy

1 reference

12 December 2020

Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma

1 reference

12 December 2020

Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

12 December 2020

Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child

1 reference

12 December 2020

cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

24-hour infusion of cis-platinum in head and neck cancers

1 reference

12 December 2020

1 reference

12 December 2020

Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy

1 reference

12 December 2020

Phase II study of continuous-infusion diaziquone in relapsed/refractory acute nonlymphocytic leukemia

1 reference

12 December 2020

Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity

1 reference

12 December 2020

Possible mechanisms for the antitumor activity of platinum coordination complexes

1 reference

12 December 2020

The hemolytic uremic syndrome

1 reference

12 December 2020

Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma

1 reference

12 December 2020

Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein

1 reference

12 December 2020

Endogenous Creatinine Clearance as a Clinical Measure of Glomerular Filtration Rate

1 reference

12 December 2020

Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C

1 reference

12 December 2020

5-Azacytidine and renal tubular dysfunction.

1 reference

12 December 2020

Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients

1 reference

12 December 2020

Clinical effects and toxicity of interleukin-2 in patients with cancer

1 reference

12 December 2020

In vivo studies on the relationship between hepatic metabolism and the renal toxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU)

1 reference

12 December 2020

Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.

1 reference

12 December 2020

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

1 reference

12 December 2020

Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review

1 reference

12 December 2020

Clinical toxicity of interferons in cancer patients: a review

1 reference

12 December 2020

Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child

1 reference

12 December 2020

Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma

1 reference

12 December 2020

Renal impairment following the combined use of high-dose methotrexate and procarbazine

1 reference

12 December 2020

Urinary Tract Toxic Effects of Cancer Therapy

1 reference

12 December 2020

Acute renal failure associated with intraperitoneal cisplatin chemotherapy with systemic thiosulfate protection in ovarian cancer patients.

1 reference

12 December 2020

Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus

1 reference

12 December 2020

Investigations on the subclinical and clinical nephrotoxicity of interferon alpha-2B in patients with myeloproliferative syndromes

1 reference

12 December 2020

Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis

1 reference

12 December 2020

Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection

1 reference

12 December 2020

Renal toxicity of cisplatin in children

1 reference

12 December 2020

Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.

1 reference

12 December 2020

Protective effects of betamipron on renal toxicity during repeated cisplatin administration in rats and protective mechanism

1 reference

12 December 2020

Ifosfamide nephrotoxicity: deleterious effect of previous cisplatin administration

1 reference

12 December 2020

Progressive renal toxicity due to ifosfamide

1 reference

12 December 2020

Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

12 December 2020

Ifosfamide, Fanconi's syndrome, and rickets

1 reference

12 December 2020

Ifosfamide-induced Fanconi syndrome

1 reference

12 December 2020

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer

1 reference

12 December 2020

Clinical experience with mitomycin C (NSC-26980).

1 reference

12 December 2020

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group

1 reference

12 December 2020

The use of lithium clearance measurements as an estimate of glomerulo-tubular function

1 reference

12 December 2020

Assessment of chemotherapy-associated nephrotoxicity in children with cancer

1 reference

12 December 2020

Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity

1 reference

12 December 2020

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor

1 reference

12 December 2020

Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection.

1 reference

12 December 2020

Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial

1 reference

12 December 2020

Nephrotoxicity of streptozotocin (NSC-85998).

1 reference

12 December 2020

Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children

1 reference

12 December 2020

Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy

1 reference

12 December 2020

Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness

1 reference

12 December 2020

The influence of age on nephrotoxicity following chemotherapy in children

1 reference

12 December 2020

A comparison of the renal handling of 99Tcm-DTPA and 99Tcm-MAG3 in hypertensive patients using an uptake technique.

1 reference

12 December 2020

Phase I Clinical and Pharmacokinetic Study of Diethyldithiocarbamate as a Chemoprotector From Toxic Effects of Cisplatin

1 reference

12 December 2020

Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome

1 reference

12 December 2020

The influence of ifosfamide scheduling on acute nephrotoxicity in children

1 reference

12 December 2020

Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults

1 reference

12 December 2020

Nephrotoxicity of streptozocin

1 reference

12 December 2020

Cisplatin nephrotoxicity: experimental and clinical studies

1 reference

12 December 2020

Severe renal failure following high-dose ifosfamide and mesna

1 reference

12 December 2020

Urinary microalbumin and retinol-binding protein assay for verifying children's nephron development and maturation

1 reference

12 December 2020

Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen

1 reference

12 December 2020

Mechanisms of cellular injury in ischemic acute renal failure

1 reference

12 December 2020

Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II).

1 reference

12 December 2020

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

Mitomycin C in large infrequent doses in breast cancer

1 reference

12 December 2020

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

1 reference

12 December 2020

Renal dysfunctions secondary to ifosfamide treatment in children

1 reference

12 December 2020

Phase I-II study of two consecutive courses of high-dose epipodophyllotoxin, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors

1 reference

12 December 2020

Nephrotoxicity of nitrosoureas

1 reference

12 December 2020

Clinical pharmacology of deoxycoformycin

1 reference

12 December 2020

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

1 reference

12 December 2020

Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in man

1 reference

12 December 2020

High-dose cisplatin with sodium thiosulfate protection.

1 reference

12 December 2020

Renal toxicity in man treated with mitomycin C

1 reference

12 December 2020

THE GROWTH AND MATURATION OF HUMAN GLOMERULI AND PROXIMAL CONVOLUTIONS FROM TERM TO ADULTHOOD: STUDIES BY MICRODISSECTION

1 reference

12 December 2020

METHODS OF MEASURING GLOMERULAR-FILTRATION RATE: A COMPARISON OF INULIN, VITAMIN-B 12 AND CREATININE CLEARANCES

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Ifosfamide, mesna, and nephrotoxicity in children

1 reference

12 December 2020

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support

1 reference

12 December 2020

Acute renal failure and nephrotic syndrome with alpha interferon therapy.

1 reference

12 December 2020

Effects of interleukin-2 immunotherapy on renal function

1 reference

12 December 2020

Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin

1 reference

12 December 2020

Methotrexate nephrotoxicity

1 reference

12 December 2020

Fanconi syndrome after ifosfamide

1 reference

12 December 2020

Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature

1 reference

12 December 2020

Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removal

1 reference

12 December 2020

Toxicity of low dose methotrexate in rheumatoid arthritis.

1 reference

12 December 2020

Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil

1 reference

12 December 2020

The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function

1 reference

12 December 2020

Diagnostic value of analysis of cystatin C and protein HC in biological fluids

1 reference

12 December 2020

Cisplatin-associated hemolytic uremic syndrome

1 reference

12 December 2020

Current experience with high-dose carboplatin therapy

1 reference

12 December 2020

Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer.

1 reference

12 December 2020

Tubular nephrotoxicity during long-term ifosfamide and mesna therapy

1 reference

12 December 2020

Reversible renal failure in a patient with the hypereosinophilia syndrome during therapy with alpha interferon

1 reference

12 December 2020

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells

1 reference

12 December 2020

New approaches to cancer chemotherapy with methotrexate

1 reference

12 December 2020

Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells

1 reference

12 December 2020

Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients

1 reference

12 December 2020

Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma

1 reference

12 December 2020

Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma

1 reference

12 December 2020

Renal, volume, and hormonal changes during therapeutic administration of recombinant interleukin-2 in man.

1 reference

12 December 2020

The effect of cisplatin on renal function in patients with testicular tumours

1 reference

12 December 2020

Acute renal failure associated with alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

12 December 2020

10.2165/00002018-200124010-00003

Identifiers

DOI

1 reference

PubMed ID

11219485

Dimensions Publication ID

6 July 2017

0 references

1 reference

PubMed ID

11219485